Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantationMatthew P Wright, John D Shepherd, Michael J Barnett, et al.Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.Leukemia & Lymphoma|July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionKevin W Song, Peter N Mollee, Donna E Hogge, et al.British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2018
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted AnalysisWasithep Limvorapitak, Michael J Barnett, Donna E Hogge, et al.Pageof 4